Fulgent Genetics, Inc.FLGTNASDAQ

Revenue (LTM)

$323M

+13.8% YoY

Net Income (LTM)

$-61M

-41.7% YoY

Free Cash Flow

$-124M

Revenue CAGR (5Y)

-24.5%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	993	619↓37.6%	289↓53.3%	283↓2.0%	323↑13.8%
Gross Profit	777	367↓52.8%	104↓71.5%	107↑2.6%	131↑22.1%
Operating Income	676	179↓73.6%	-196↓209.5%	-74↑62.2%	-91↓23.2%
Net Income	507	143↓71.7%	-168↓217.0%	-43↑74.6%	-61↓41.7%
EBITDA	687	218↓68.3%	-147↓167.7%	-49↑66.8%	-46↑6.5%
EPS Diluted	16.26	4.63↓71.5%	-5.63↓221.6%	-1.41↑75.0%	-1.97↓39.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	165	80↓51.8%	97↑22.6%	55↓43.4%	50↓9.0%
Total Current Assets	612	628↑2.6%	508↓19.1%	354↓30.4%	550↑55.7%
Total Assets	1,279	1,386↑8.4%	1,235↓10.9%	1,220↓1.2%	1,214↓0.5%
Total Current Liabilities	105	88↓16.3%	73↓17.1%	73↓0.2%	85↑16.6%
Total Liabilities	113	116↑3.0%	102↓12.2%	91↓11.0%	107↑17.6%
Total Equity	1,159	1,267↑9.3%	1,136↓10.3%	1,133↓0.3%	1,112↓1.9%
Total Debt	21	39↑82.9%	15↓60.8%	8↓44.5%	0↓94.4%
Net Debt	-144	-41↑71.8%	-82↓102.7%	-47↑43.2%	-50↓6.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	539	254↓52.9%	27↓89.3%	21↓22.0%	-102↓582.6%
Capital Expenditure	-24	-19↑21.3%	-22↓18.3%	-40↓81.5%	-23↑44.0%
Free Cash Flow	515	235↓54.4%	5↓98.0%	-19↓501.5%	-124↓545.1%
Stock-Based Comp	16	33↑105.5%	43↑31.5%	44↑3.6%	40↓11.0%
Net Change in Cash	77	-85↓210.2%	18↑121.0%	-42↓334.8%	-5↑88.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance